Topical drug development presents unique clinical pharmacology and regulatory considerations. Drugs administered to the skin must overcome biological barriers while delivering the desired therapeutic effect locally or systemically.
In this webinar, experts discuss important factors involved in dermatology drug development, including formulation strategies, pharmacokinetic evaluation of topical drugs, and regulatory considerations for topical therapies.
Developing dermatology drugs requires careful consideration of formulation, skin penetration, and systemic exposure. Small changes in excipients or formulation design can significantly influence drug absorption through the skin. In addition, pharmacokinetic studies are often needed to understand systemic exposure, evaluate safety, and support regulatory submissions for topical drugs.
These considerations are essential when designing clinical development programs for dermatology therapies and ensuring regulatory compliance.
What This Webinar Covers:
• Key formulation considerations for dermatology drugs applied to the skin
• Pharmacokinetic evaluation of topically administered drugs
• Regulatory requirements for topical drug development
• Clinical pharmacology considerations for dermatology therapies
• Study design considerations such as maximum use trials
Request a Proposal
Share This
